乌尔特拉帕

最新新闻

• 公司公告
  TELA Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EW Healthcare Partners Fund 2-UGP, LLC(10.44%),EW Healthcare Partners Fund 2-GP, L.P.(10.44%), etc.
  SEC · 2024/10/29
• 评级变动
  Goldman Sachs Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Announces Target Price $5.4
  \u5e02\u573a\u8d44\u8baf · 2026/2/5
• 评级变动
  Goldman Sachs Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Cuts Target Price to $4.1
  \u5e02\u573a\u8d44\u8baf · 2025/1/17
• 评级变动
  HSBC Upgrades Ultrapar Participacoes(UGP.US) to Buy Rating, Announces Target Price $3.7
  \u5e02\u573a\u8d44\u8baf · 2025/1/17
• 公司公告
  Root Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ribbit Capital GP IV, L.P. (“GP IV”)(15.3%),Ribbit Capital GP IV, Ltd. (“UGP IV”)(15.3%), etc.
  SEC · 2024/11/14
• 评级变动
  TR | OpenAI - 4o Maintains Ultrapar Participacoes(UGP.US) With Buy Rating, Maintains Target Price $3.5
  \u5e02\u573a\u8d44\u8baf · 2025/8/10
• 公司公告
  SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Chicago Pacific Founders UGP III, LLC(46.88%),Chicago Pacific Founders GP III, L.P.(46.88%), etc.
  SEC · 2024/11/9
• 评级变动
  Goldman Sachs Upgrades Ultrapar Participacoes(UGP.US) to Buy Rating, Cuts Target Price to $3.2
  \u5e02\u573a\u8d44\u8baf · 2025/1/31
• HSBC Downgrades Ultrapar Participacoes(UGP.US) to Hold Rating, Raises Target Price to $6
  \u5e02\u573a\u8d44\u8baf · 2026/4/8
• Goldman Sachs Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Cuts Target Price to $6.5
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• Goldman Sachs Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Raises Target Price to $7.3
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Goldman Sachs Downgrades Ultrapar Participacoes(UGP.US) to Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/2/5
• 公司公告
  TELA Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-EW Healthcare Partners Fund 2-UGP, LLC(16.79%),EW Healthcare Partners Fund 2 GP, L.P.(16.79%), etc.
  SEC · 2024/2/14
• 公司公告
  N-able | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Thoma Bravo UGP, LLC(27.0%),Thoma Bravo Partners XI, L.P.(18.7%), etc.
  SEC · 2024/11/13
• Ultrapar Participacoes SA (UGP) Q4 2025 Earnings Call Highlights: Record Operational Cash Flow ...
  Yahoo Finance · 2026/3/10
• Earnings Call Summary | Ultrapar Participacoes(UGP.US) Q4 2025 Earnings Conference
  \u5e02\u573a\u8d44\u8baf · 2026/3/6
• 评级变动
  Banco Santander Upgrades Ultrapar Participacoes(UGP.US) to Buy Rating, Raises Target Price to $4
  \u5e02\u573a\u8d44\u8baf · 2025/8/14
• 评级变动
  BofA Securities Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Raises Target Price to $3.7
  \u5e02\u573a\u8d44\u8baf · 2025/5/6
• 评级变动
  BofA Securities Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Cuts Target Price to $3.5
  \u5e02\u573a\u8d44\u8baf · 2025/2/7
• 评级变动
  J.P. Morgan Initiates Ultrapar Participacoes(UGP.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2025/1/8

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。